Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Der Nervenarzt
Erschienen in: Der Nervenarzt 5/2004

01.05.2004 | Übersicht

Die Bedeutung des Schlafs für gesunde Alkoholkonsumenten und alkoholabhängige Patienten

verfasst von: Priv.-Doz. Dr. H. Gann, D. van Calker, B. Feige, D. Riemann

Erschienen in: Der Nervenarzt | Ausgabe 5/2004

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Auswirkungen von Alkohol auf den Schlaf und das Schlaf-EEG bei Gesunden und Alkoholabhängigen in den verschiedenen Phasen der Abhängigkeit werden dargestellt. Gesunde schlafen zunächst besser. Eine höhere Dosis kann aber zur Durchschlafstörung in der 2. Nachthälfte führen. Alkohol interagiert mit einer vorhergehenden Schlafdeprivation oder -restriktion.
Schlafstörungen finden sich häufiger bei Alkoholkranken als bei Gesunden und können die Entwicklung einer Alkoholerkrankung begünstigen. Bei Alkoholkranken finden sich in allen Phasen der Erkrankung Einschlafstörungen und eine verminderte Gesamtschlafzeit sowie überzufällig häufig andere Schlafstörungen, wie Schlafapnoe-Syndrom oder periodische Beinbewegungen im Schlaf. . Es fanden sich Prädiktoren für ein erhöhtes Rückfallrisiko bei abstinenten Alkoholkranken.
Die Neurobiologie des Schlafs und der Alkoholabhängigkeit wird diskutiert. Eine wichtige Bedeutung kommt hierbei dem cholinerg-aminergen reziproken Interaktionsmodell der REM- und Non-REM-Schlafregulation zu. Therapeutische Implikationen werden diskutiert.
Literatur
1.
Aalto J, Hilakivi L (1986) Differences in the slee-wake patterns of the AA and ANA rat lines developed for high and low alcohol intake. Alcohol 3: 77–79CrossRefPubMed
2.
Adamson J, Burdick JA (1973) Sleep of dry alcoholics. Arch Gen Psychiatry 28: 146–149PubMed
3.
Aguayo LG, Peoples RW, Yeh HH, Yevenes GE (2002) GABA(A) receptors as molecular sites of ethanol action. Direct or indirect actions? Curr Top Med Chem 2: 869–885PubMed
4.
Aldrich MS (1998) Effects of alcohol on sleep. In: Gomberg ESL, Hegedus AM, Zucker RA (eds) Alcohol problems and aging. National Institute on Alcohol Abuse and Alcoholism Research Monograph No. 33. NIH Publication No. 98–4163. Bethesda/MD: National Institutes of Health, pp 281–300
5.
Aldrich MS, Brower KJ, Hall JM (1999) Sleep-disordered breathing in alcoholics. Alcohol Clin Exp Res 23: 134–140PubMed
6.
Allen RP, Wagman AM (1975) Do sleep patterns relate to the desire for alcohol? Adv Exp Med Biol 59: 495–508PubMed
7.
Allen RP, Wagman AM, Funderburk FR (1977) Slow wave sleep changes: Alcohol tolerance and treatment implications. Adv Exp Med Biol 85A: 629–640PubMed
8.
Allen RP, Wagman AM, Funderburk FR, Wells DT (1980) Slow wave sleep: A predictor of individual differences in response to drinking? Biol Psychiatry 15: 345–348PubMed
9.
Aubin HJ, Goldenberg F, Benoit O et al. (1994) Effects of tetrabamate and of diazepam on sleep polygraphy during subacute withdrawal in alcohol-dependent patients. Hum Psychopharmacol 9: 191–195
10.
Backhaus J, Riemann D (1999) Schlafstörungen. Fortschritte der Psychotherapie Bd 7. Hogrefe, Göttingen
11.
Baekeland F, Lundwall L, Shanahan TJ, Kissin B (1974) Clinical correlates of reported sleep disturbance in alcoholics. Q J Stud Alc 35: 1230–1241
12.
Benca RM, Obermeyer WH, Thisted RA, Gillin JC (1992) Sleep and psychiatric disorders: A meta-analysis. Arch Gen Psychiatry 49: 651–668PubMed
13.
Brower KJ, Aldrich MS, Hall JM (1998) Polysomnographic and subjective sleep predictors of alcoholic relapse. Alcohol Clin Exp Res 22: 1864–1871PubMed
14.
Brower KJ, Robinson EAR, Zucker RA (2000). Epidemiology of insomnia and alcoholism in the general population. Alcohol Clin Exp Res 24 (suppl. 5): 43A
15.
Brower, KJ, Hall JM (2001) Effects of age and alcoholism on sleep: A controlled study. J Stud Alcohol 62: 335–343PubMed
16.
Brower KJ, Aldrich MS, Robinson EAR, Zucker RA, Greden JF (2001) Insomnia, self-medication, and relapse to alcoholism. Am J Psychiatry 158: 399–404CrossRefPubMed
17.
Caetano R, Clark CL, Greenfield TK (1998) Prevalence, trends, and incidence of alcohol withdrawal symptoms: Analysis of general population and clinical samples. Alcohol Health Res World 22: 73–79
18.
Cagetti E, Liang J, Spigelman I, Olsen RW (2003) Withdrawal from chronic intermittent ethanol treatment changes subunit composition, reduces synaptic function, and decreases behavioral responses to positive allosteric modulators of GABA (A) receptors. Mol Pharmacol 63: 53–64CrossRefPubMed
19.
Carmichael FJ, Israel Y, Crawford M, Minhas K, Saldivia V, Sandrin S, Campisi P, Orrego E (1991) Central nervous system effects of acetate: contribution to the central effects of ethanol. Pharmacol Exp Ther 259: 403–408
20.
Caron MH, Alling C (2001) Role of nitric oxide in ethanol-induced up-regulation of muscarinic acetylcholine receptors in SH-SY5Y cells. Alcohol Clin Exp Res 25: 1107–1113PubMed
21.
Clark CP, Gillin JC, Golshan S et al. (1998) Increased REM sleep density at admission predicts relapse by three months in primary alcoholics with a lifetime diagnosis of secondary depression. Biol Psychiatry 43: 601–607CrossRefPubMed
22.
Diamond I, Nagy L, Mochly-Rosen D, Gordon A (1991) The role of adenosine and adenosine transport in ethanol-induced cellular tolerance and dependence. Possible biologic and genetic markers of alcoholism. Ann N Y Acad Sci 625: 473–487PubMed
23.
Diamond I, Gordon AS (1997) Cellular and molecular neuroscience of alcoholism. Physiol Rev 77: 1–20PubMed
24.
Dijk DJ, Brunner DP, Aeschbach D et al. (1992) The effects of ethanol on human sleep EEG power spectra differ from those of benzodiazepine receptor agonists. Neuropsychopharmacology 7: 225–232PubMed
25.
Drummond SPA, Gillin JC, Smith TL, Demodena A (1998) The sleep of abstinent pure primary alcoholic patients: Natural course and relationship to relapse. Alcohol Clin Exp Res 22: 1796–1802PubMed
26.
Dunwiddie TV (1999) Adenosine and ethanol: is there a caffeine connection in the actions of ethanol? In: Liu Y, Hunt WA (eds) The „drunken“ synapse: Studies of alcohol-related disorders. Kluwer/Plenum, New York, pp 119–133
27.
Dunwiddie TV, Masino SA (2001) The role and regulation of adenosine in the central nervous system. Ann Rev Neurosci 24: 31–55CrossRefPubMed
28.
Ehlers CL (2000) Alcohol and sleep. In: Noronha A, Eckardt M, Warren K (eds) Review of NIAAA’s Neuroscience and Behavioral Research Portfolio. National Institute on Alcohol Abuse and Aldoholism Research Monograph No. 34. NIH Publication No. 00–4520. Bethesda, MD: the Institute, pp 417–433
29.
Esteban S, Morantaf D, Sastre-Coll A, Miralles A, Garcia-Sevilla JA (2002) Withdrawal from chronic ethanol increases the sensitivity of presynaptic 5-HAT(1A) receptors modulating serotonine and dopamine synthesis in rat brain in vivo. Neurosci Lett 28: 121–124CrossRef
30.
Faulhaber J, Steiger A, Lancel M (1997) The GABAA agonist THIP produces slow wave sleep and reduces spindling activity in NREM sleep in humans. Psychopharmacology 130: 285–291
31.
Feuerlein W (1974) The acute alcohol withdrawal syndrome: Findings and problems. Br J Addict 69: 141–148
32.
Fischer J, Mayer G, Peter JH, Riemann D, Sitter H (2001) Nicht-erholsamer Schlaf. Somnologie 5 (Suppl 3): 1–258
33.
Foster JH, Peters TJ (1999) Impaired sleep in alcohol misusers and dependent alcoholics and the impact upon outcome. Alcohol Clin Exp Res 23: 1044–1051PubMed
34.
Foster JH, Marshall EJ, Peters TJ (2000) Application of a quality of life measure, the life situation survey (LSS), to alcohol-dependent subjects in relapse and remission. Alcohol Clin Exp Res 24: 1687–1692PubMed
35.
Gann H, Kiemen A, Klein T et al. (1997) Schlaf und cholinerger REM-Schlaf-Induktionstest bei Patienten mit primärer Alkoholabhängigkeit. Somnologie 1: 119–125
36.
Gann H, Faulmann A, Kiemen A et al. (1998) Sleep and the cholinergic REM sleep induction test in patients with primary alcoholism. Sleep Research Online 1: 92–95PubMed
37.
Gann H, Ebersholdt M, Adamovic K, van Calker (1999) Agonist-stimulated Ca2+-response in neutrophils from patients with primary alcoholism and alcoholized healthy subjects. Psychiatry Res 89:189–199CrossRefPubMed
38.
Gann H, Landbrecht M, Feige B, Hohagen F, Riemann D (2001a) Subjektive Parameter des Schlafs bei Patienten mit primärer Alkoholabhängigkeit. Somnologie 5: 65–70CrossRef
39.
Gann H, Feige B, Hohagen F et al. (2001b) Sleep and the cholinergic REM sleep induction test in patients with primary alcoholism. Biol Psychiatry 50: 383–390CrossRefPubMed
40.
Gann H, Feige B, Fasihi S et al. (2002) Periodic limb movements during sleep in alcohol dependent patients. Eur Arch Psychiatry Clin Neurosci 252: 124–129PubMed
41.
Gann H, Feige B, Cloot O et al. (2003) Polysomnography during withdrawal with clomethiazole or placebo in alcohol dependent patients—a double-blind and randomized study. Pharmacopsychiatry (in press)
42.
Gillin JC, Smith TL, Irwin M et al. (1990a) Short REM latency in primary alcoholic patients with secondary depression. Am J Psychiatry 147: 106–109PubMed
43.
Gillin JC, Smith TL, Irwin M, Kripke DF, Schuckit M (1990b) EEG sleep studies in „pure“ primary alcoholism during subacute withdrawal: Relationships to normal controls, age, and other clinical variables. Biol Psychiatry 27: 477–488CrossRefPubMed
44.
Gillin JC, Smith TL, Irwin M et al. (1994) Increased pressure for rapid eye movement sleep at time of hospital admission predicts relapse in non-depressed patients with primary alcoholism at 3-month follow up. Arch Gen Psychiatry 51: 189–197PubMed
45.
Gillin JC (1998) Are sleep disturbances risk factors for anxiety, depressive and addictive disorders? Acta Psychiatr Scand (Suppl) 393: 39–43
46.
Gillin JC, Drummond SP (2000) Medication and substance abuse. In: Kryger MH, Roth T, Dement WC (eds) Principles and practice of sleep medicine. 3rd ed. Saunders, Philadelphia/PA, pp 1176–1195
47.
Greeff AP, Conradi WS (1998) Use of progressive relaxation training for chronic alcoholics with insomnia. Psychol Rep 82: 407–412PubMed
48.
Greenberg R, Pearlman C (1967) Delirium tremens and dreaming. Am J Psychiatry 124: 133–142PubMed
49.
Gresham SC, Webb WB, Williams RL (1963) Alcohol and caffeine: effect on inferred visual dreaming. Science 140: 1226–1227PubMed
50.
Grobin AC, Matthews DB, Devaud LL, Morrow AL (1998) The role of GABA(A) receptors in the acute and chronic effects of ethanol. Psychopharmacology 139: 2–19PubMed
51.
Gross MM, Goodenough D, Tobin M et al. (1966) Sleep disturbances and hallucinations in the acute alcoholic psychoses. J Nerv Ment Dis 142: 493–514PubMed
52.
Gross MM, Goodenough DR, Hastey J, Lewis E (1973) Experimental study of sleep in chronic alcoholics before, during and after four days of heavy drinking with a nondrinking comparison. Ann N Y Acad Sci 215: 254–265PubMed
53.
Gross MM, Hastey JM (1975) The relation between baseline slow wave sleep and the slow wave sleep response to alcohol in alcoholics. Adv Exp Med Biol 59: 467–475PubMed
54.
Gross MM, Hastey JM (1976) Sleep disturbances in alcoholism. In: Tarter RE, Sugarman AA (eds) Alcoholism: Interdisciplinary approaches to an enduring problem. Addison-Wesley, Reading/MA, pp 257–307
55.
Guizzetti M, Moller T, Costa LG (2003) Ethanol inhibits muscarinic receptor-mediated DANN synthesis and signal transduction in human fetal astrocytes. Neurosci Lett 344: 68–70CrossRefPubMed
56.
Hajak G, Rodenbeck A, Voderholzer U et al. (2001) Doxepin in the treatment of primary insomnia- a placebo-controlled, double-blind, polysomnographic study. J Clin Psychiatry 62: 453–463PubMed
57.
Harris RA, Allan AM (1989) Alcohol intoxication: ion channels and genetics. FASEB J 3: 1689–1695PubMed
58.
Hobson JA, Lydic R, Baghdoyan HA (1986) Evolving concepts of sleep cycle generation: From brain centers to neuronal populations. Behav Brain Sci 9: 371–448
59.
Imatoh N, Nakazawa Y, Ohshima H, Ishibashi M, Yokoyama T (1986) Circadian rhythm of REM sleep of chronic alcoholics during alcohol withdrawal. Drug Alcohol Depend 18: 77–85PubMed
60.
Irwin M, Miller C, Gillin JC, Demodena A, Ehlers CL (2000) Polysomnographic and spectral sleep EEG in primary alcoholics: An interaction between alcohol dependence and Africa-American ethnicity. Alcohol Clin Exp Res 24: 1376–1384PubMed
61.
Ishibashi M, Nakazawa Y, Yokoyama T et al. (1987) Cerebral atrophy and slow wave sleep of abstinent chronic alcoholics. Drug Alcohol Depend 19: 325–332PubMed
62.
Johnson LC, Burdick JA, Smith J (1970) Sleep during alcohol intake and withdrawal in the chronic alcoholic. Arch Gen Psychiatry 22: 406–418PubMed
63.
Johnson BA, Jasinski DR, Galloway GP et al. (1996) Ritanserin in the treatment of alcohol dependence—a multi-center clinical trial. Ritanserin Study Group. Psychopharmacology 128: 206–215
64.
Johnson EO, Roehrs T, Roth T, Breslau N (1998) Epidemiology of alcohol and medication as aids to sleep in early adulthood. Sleep 21: 178–186PubMed
65.
Jones BE (2003) Arousal systems. Front Biosci 8: 438–451
66.
Karam-Hage M, Brower KJ (2000) Gabapentin treatment for insomnia associated with alcohol dependence (letter) Am J Psychiatry 157: 151
67.
Knowles JB, Laverty SG, Kuechler HA (1968) Effects of alcohol on REM sleep. Q J Stud Alcohol 29: 342–349PubMed
68.
Kotorie T, Nakazawa Y, Yokoyama T et al. (1982) Terminal sleep following delirium tremens in chronic alcoholics—Polysomnographic and behavioral study. Drug Alcohol Depend 10: 125–134PubMed
69.
Kumari M, Ticku MK (2000) Regulation of NMDA receptors by ethanol. Prog Drug Res 54: 152–189PubMed
70.
Landolt HP, Roth C, Dijk DJ et al. (1996) Late-afternoon ethanol intake affects nocturnal sleep and the sleep EEG in middle-aged men. J Clin Psychopharmacol 16: 428–436CrossRefPubMed
71.
Landolt HP, Gillin JC (2001) Sleep abnormalities during abstinence in alcohol-dependent patients. CNS Drugs 15: 413–425PubMed
72.
Le Bon O, Verbanck P, Hoffmann G et al. (1997) Sleep in detoxified alcoholics: Impairment of most standard sleep parameters and increased risk for sleep apnea, but not myoclonias—A controlled study. J Stud Alcohol 58: 30–36PubMed
73.
Longo LP, Johnson B (1998) Treatment of insomnia in substance abusing patients. Psychiatr Ann 28: 154–159
74.
Lovinger DM (1999) 5-HT3 receptors and the neural actions of alcohol: an increasingly exciting topic. Neurochem Int 35: 125–130CrossRefPubMed
75.
MacLean AW, Cairns J (1982) Dose-response effects of ethanol on the sleep of young men. J Stud Alcohol 43: 434–444PubMed
76.
Madsen BW, Rossi L (1980) Sleep and Michaelis-Menten elimination of ethanol. Clin Pharmacol Ther 27: 114–119PubMed
77.
Mandani M, Hollyfield R, Ravi RD, Dorus W, Borge GF (1989) Prevalence of sleep apnea among abstinent chronic alcoholic men (abstract). Sleep Res 18: 349
78.
Maxion H, Schneider E (1970) Der Einfluss von Clomethiazol (Distraneurin) auf das Schlaf-Elektroenzephalogramm nach Alkoholdelir. Pharmakopsychiatrie, Neuro-Psychopharmakologie 3: 233–238
79.
Mello NK, Mendelson JH (1970) Behavioral studies of sleep patterns in alcoholics during intoxication and withdrawal. J Pharmacol Exp Ther 175: 94–112PubMed
80.
Moeller FG, Gillin JC, Irwin M et al. (1993) A comparison of sleep EEGs in patients with primary major depression and major depression secondary to alcoholism. J Affect Disord 27: 39–42CrossRefPubMed
81.
Monti JM, Alterwain P (1991) Ritanserin decreases alcohol intake in chronic alcoholics (letter) Lancet 337 (8732): 60
82.
Monti JM, Alterwain P, Estevez F et al. (1993) The effects of ritanserin on mood and sleep in abstinent alcoholic patients. Sleep 16: 647–654PubMed
83.
Morin C, Culbert JP, Schwartz SM (1994) Nonpharmacological interventions for insomnia: a meta-analysis. Am J Psychiatry 151: 1172–1180.PubMed
84.
Murtagh DR, Greenwood KM (1995) Identifying effective psychological treatments for insomnia: a meta-analysis. J Clin Consult Psychol 63: 79–89CrossRef
85.
National Institute on Alcohol Abuse and Alcoholism (1998) Alcohol Alert No. 41: Alcohol and sleep. Bethesda MD: the Institute
86.
National Sleep Foundation. 2000 Omnibus sleep in America poll. (Web page available in year 2000 at www.sleepfoundation.org/publications/2000poll.html [accessed on January 9, 2001])
87.
Pandey SC, Piano MR, Schwertz DW, Davis JM, Pandey GN (1992) Effect of ethanol administration and withdrawal on serotonin receptor subtypes and receptor-mediated phosphoinositide hydrolysis in rat brain. Alcohol Clin Exp Res 16: 1110–1116PubMed
88.
Papineau K, Roehrs T, Petrucelli N, Rosenthal L, Roth T (1988) Electrophysiological assessment (Multiple Sleep Latency Test) of the biphasic effects of ethanol in humans. Alcohol Clin Exp Res 22: 231–235
89.
Poelchen W, Proctor WR, Dunwiddie TV (2000) The in vitro ethanol sensitivity of hippocampal synaptic gamma-aminobutyric acid (A) responses differs in lines of mice and rats genetically selected for behavioral sensitivity or insensitivity to ethanol. J Pharmacol Exp Ther 295: 741–746PubMed
90.
Pohorecky LA (1977) Biphasic action of ethanol. Biobehavior Reviews 1: 231–240CrossRef
91.
Proctor WR, Poelchen W, Bowers BJ, Wehner JM, Messing RO, Dunwiddie TV (2003) Ethanol differenzially enhances hippocampal GABA A receptor-mediated responses in protein kinase C gamma (PKC gamma) and PKC epsilon null mice. J Pharmacol Exp Ther 305: 264–270CrossRefPubMed
92.
Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human sleep. Washington DC: National Institute of Health Publications, US Government Printin Office
93.
Riemann D, Backhaus J (1996) Schlafstörungen bewältigen—ein psychologisches Gruppenprogramm. Beltz PVU, Weinheim
94.
Riemann D, Voderholzer U, Cohrs S et al. (2002) Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study. Pharmacopsychiatry 35: 165–174CrossRefPubMed
95.
Roehrs T, Yoon J, Roth T (1991) Nocturnal and next-day effects of ethanol and basal level of sleepiness. Hum Psychopharmacology 6: 307–311
96.
Roehrs T, Beare D, Zorick F et al. (1994) Sleepiness and ethanol effects on simulated driving. Alcohol Clin Exp Res 18: 154–156PubMed
97.
Roehrs T, Roth T (1995) Alcohol-induced sleepiness and memory function. Alcohol Health Res World 19: 130–135
98.
Roehrs T, Roth T (1998) State-altering actions of ethanol, caffeine, and nicotine. In: Lydic R, Baghdoyan HA (eds) Handbook of Behavioral State Control—Cellular and Molecular Mechanisms. CRC Press, New York, pp 421–432
99.
Roehrs T, Papineau K, Rosenthal L, Roth T (1999) Ethanol as a hypnotic in insomniacs: Self administration and effects of sleep and mood. Neuropsychopharmacology 20: 279–286CrossRefPubMed
100.
Roth T, Ancoli-Israel S (1999) Daytime consequences and correlates of insomnia in the United States: Results of the 1991 National Sleep Foundation Survey. II. Sleep 22 (suppl. 2): S354-S358
101.
Rundell OH, Lester BK, Griffiths WJ et al. (1972) Alcohol and sleep in young adults. Psychopharmacologia 26: 201–218PubMed
102.
Sapru MK, Diamond I, Gordon AS (1994) Adenosine receptors mediate cellular adaptation to ethanol in NG 108–15 cells. J Pharmacol Exp Ther 27: 542–548
103.
Satel SL, Kosten TR, Schuckit MA, Fischman MW (1993) Should protracted withdrawal from drugs be included in DSM-IV? Am J Psychiatry 150: 695–704PubMed
104.
Schiavi RC, Stimmel BB, Mandelli J, White D (1995) Chronic alcoholism and male sexual function. Am J Psychiatry 152: 1045–1051PubMed
105.
Skoloda TE, Alterman AI, Gottheil EL (1979) Sleep quality reported by drinking and non-drinking alcoholics. In: Gottheil EL (ed) Addiction Research and Treatment: Converging Trends. Pergamon, Elmsford, NY, pp 102–112
106.
Smith ML, Perlis ML, Park A et al. (2002) Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 159: 5–11CrossRefPubMed
107.
Stoller MK (1994) Economic effects of insomnia. Clin Ther 16: 873–897PubMed
108.
Tan ET, Lambie DG, Johnson RH, Robinson BJ, Whiteside EA (1985) Sleep apnea in alcoholic patients after withdrawal. Clin Sci 69: 655–661PubMed
109.
VanCauter E, Plat L, Scharf MB et al. (1997) Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young men. J Clin Invest 100: 745–753PubMed
110.
Vitiello MV, Prinz PN, Personius JP et al. (1990) Nighttime hypoxemia is increased in abstaining chronic alcoholic men. Alcohol Clin Exp Res 14: 38–41PubMed
111.
Wagman AM, Allen RP (1975) Effects of alcohol ingestion and abstinence on slow wave sleep of alcoholics. Adv Exp Med Biol 59: 453–466PubMed
112.
Weissman MM, Greenwald S, Nino-Murcia G, Dement WC (1997) The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry 19: 245–250CrossRefPubMed
113.
Wetter DW, Young TB (1994) The relation between cigarette smoking and sleep disturbance. Prev Med 23: 328–334CrossRefPubMed
114.
Williams HL, Rundell OH (1981) Altered sleep physiology in chronic alcoholics: Reversal with abstinence. Alcohol Clin Exp Res 2: 318–325
115.
Williams DL, MacLean AW, Cairns J (1983) Dose-response effects of ethanol on the sleep of young women. J Stud Alcohol 44: 515–523PubMed
116.
Wirkner K, Poelchen W, Koles L et al. (1999) Ethanol-induced inhibition of NMDA receptor channels. Neurochem Int 35: 153–162PubMed
117.
Yao L, Asai K, Jiang Z et al. (2001) Dopamine D2 receptor inhibition of adenyl cyclase is abolished by acute ethanol but restored after chronic ethanol exposure. J Pharmacol Exp Ther 298: 833–839PubMed
118.
Yules RB, Freedman DX, Chandler KA (1966) The effect of ethyl alcohol on man’s electroencephalographic sleep cycle. Electroencephalogr Clin Neurophysiol 20: 109–111CrossRefPubMed
119.
Zarcone V (1978) Alcoholism and sleep. Adv Biosci 21: 29–38PubMed
Metadaten
Titel
Die Bedeutung des Schlafs für gesunde Alkoholkonsumenten und alkoholabhängige Patienten
verfasst von
Priv.-Doz. Dr. H. Gann
D. van Calker
B. Feige
D. Riemann
Publikationsdatum
01.05.2004
Verlag
Springer-Verlag
Erschienen in
Der Nervenarzt / Ausgabe 5/2004
Print ISSN: 0028-2804
Elektronische ISSN: 1433-0407
DOI
https://doi.org/10.1007/s00115-003-1637-8

Weitere Artikel der Ausgabe 5/2004

Der Nervenarzt 5/2004 Zur Ausgabe

Übersicht

Diabetes mellitus als Komplikation der Behandlung mit atypischen Neuroleptika

Nachruf

In memoriam Paul Matussek

Mitteilungen der DGPPN

Mitteilungen der DGPPN

Editorial

Sind plazebokontrollierte Studien zum Wirksamkeitsbeweis von Antidepressiva notwendig?

Ergebnisse und Kasuistik

Arzneimittelinduzierter Kopfschmerz und Schmerzmittelentzug mit Amitriptylin bei einem 11-jährigen Schüler

Ergebnisse & Kasuistik

Superfizielle Siderose des ZNS

Neu in den Fachgebieten Neurologie und Psychiatrie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Bildnachweise